EGRX - Eagle Pharmaceuticals Inc. (EGRX) CEO Scott Tarriff on Q4 2020 Results - Earnings Call Transcript

Eagle Pharmaceuticals, Inc. (EGRX) Q4 2020 Earnings Conference Call March 2, 2021, 08:30 AM ET Company Participants Lisa Wilson - IR Scott Tarriff - CEO Brian Cahill - CFO David Pernock - President and COO Judith Ng-Cashin - Chief Medical Officer Conference Call Participants Randall Stanicky - RBC Capital Markets Tim Lugo - William Blair Brandon Folkes - Cantor Fitzgerald Presentation Operator Good morning, everyone. My name is Leo. And I'll be your conference operator. At this time, I'd like to welcome everyone to Eagle Pharmaceuticals' Fourth Quarter and Full Year 2020 Financial Results and Pipeline Review Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer period. [Operator Instructions] As a reminder, this conference call is being recorded today, March 2, 2021. It is now my pleasure to turn the floor over to Ms. Lisa Wilson, Investor

For further details see:

Eagle Pharmaceuticals, Inc. (EGRX) CEO Scott Tarriff on Q4 2020 Results - Earnings Call Transcript